Synopsis: Generic medicines are cost-effective versions of patented drugs that meet identical safety and efficacy standards. India leads the global generics market due to scale, regulatory compliance, and export strength. Stocks like Sun Pharma, Cipla, Dr Reddy’s, Lupin, and Aurobindo dominate this segment with diversified portfolios and global presence. India has emerged as a global […]

The post Cipla and 4 Other Pharma Stocks Leading the Generic Medicine Segment to Watch Out For appeared first on Trade Brains.

Synopsis: Five stocks across jewellery, pharma, IT, financial services, and energy sectors have received buy calls from brokerages, with projected upside ranging between 30 percent and 51 percent. Brokerage recommendations continue to draw investor attention amid ongoing market volatility, as analysts identify select opportunities with favourable risk-reward profiles. Based on recent target price revisions and […]

The post Stocks to Buy: 5 Stocks that can deliver returns of up to 51% appeared first on Trade Brains.

Synopsis: India is entering a massive new phase of digital infrastructure growth as companies quietly plan gigawatt-scale data centre campuses to meet surging AI, cloud and data demand. This build-out could reshape the country’s tech backbone and trigger a long investment cycle across power, infrastructure and technology ecosystems. India’s digital infrastructure is entering a new […]

The post 5 Companies Setting Up Hyperscale Data Centres of More Than 1 GW in India appeared first on Trade Brains.